Combined, Reduced-Antigen Content Tetanus, Diphtheria, and Acellular Pertussis Vaccine (Boostrix®)†: A Review of its Use as a Single-Dose Booster Immunization in Individuals Aged 10-64 Years in the US

Author： Plosker Greg L.  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.23, Iss.4, 2009-08, pp. : 253-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine (Boostrix™): A Review of its Use as a Single-Dose Booster Immunization

By Frampton James E.   Keating Gillian M.  

BioDrugs, Vol. 20, Iss. 6, 2006-01 ,pp. : 371-389

Adis International

Access to resources Recommend Favorite

Tdap 5 Vaccine (Covaxis®): A Review of its Use as a Single-Booster Immunization for the Prevention of Tetanus, Diphtheria, and Pertussis in Children (Aged ≥4 Years), Adolescents, and Adults

By Scott Lesley J.  

BioDrugs, Vol. 24, Iss. 6, 2010-12 ,pp. : 387-406

Adis International

Access to resources Recommend Favorite

Antibody Responses of Healthy Infants to Concurrent Administration of a Bivalent Haemophilus influenzae Type b-Hepatitis B Vaccine with Diphtheria-Tetanus-Pertussis, Polio and Measles-Mumps-Rubella Vaccines

By West D.J.  

BioDrugs, Vol. 15, Iss. 6, 2001-06 ,pp. : 413-418

Adis International

Access to resources Recommend Favorite

Appropriate Medication Use in Individuals Aged 80 or More Years

By Marquet Thierry  

Therapie, Vol. 60, Iss. 4, 2005-01 ,pp. : 373-377

Adis International

Access to resources Recommend Favorite

Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel: A Review of its Use in the Treatment of Acne Vulgaris in Patients Aged ≥12 Years

By Keating Gillian M.  

American Journal of Clinical Dermatology, Vol. 12, Iss. 6, 2011-12 ,pp. : 407-420

Adis International

Access to resources Recommend Favorite